Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 257517, 8 pages
http://dx.doi.org/10.1155/2014/257517
Research Article

Mutation Status and Immunoglobulin Gene Rearrangements in Patients from Northwest and Central Region of Spain with Chronic Lymphocytic Leukemia

1Servicio de Hematología, Departamento de Medicina, Hospital Universitario Infanta Leonor, Calle Gran Vía del Este 80, 28031 Madrid, Spain
2Universidad Complutense de Madrid, Avenida Séneca 2, 28040 Madrid, Spain
3Servicio de Hematología, IBSAL-Hospital Universitario de Salamanca, Paseo de San Vicente 58-182, 37007 Salamanca, Spain
4Centro de Investigación del Cáncer-IBMCC, Universidad de Salamanca (USAL-CSIC), Calle Zacarías González 2, 37007 Salamanca, Spain
5Servicio de Hematología, Hospital Virgen Blanca, Calle Altos de Nava, s/n, 24071 León, Spain
6Servicio de Hematología, Hospital General de Segovia, Calle Miguel Servet, s/n, 4002 Segovia, Spain
7Servicio de Hematología, Hospital Clínico Universitario de Valladolid, Avenida Ramón y Cajal 3, 47005 Valladolid, Spain
8Servicio de Hematología, Hospital del Río Hortega, Calle Dulzaina 2, 47012 Valladolid, Spain
9Servicio de Hematología, Hospital Nuestra Señora de Sonsoles, Plaza de Santiago 1, 05002 Ávila, Spain
10Servicio de Hematología, Hospital El Bierzo, Calle Médicos sin Fronteras 7, 24411 Ponferrada, León, Spain
11Servicio de Hematología, Hospital Virgen del Puerto, Paraje Valcorchero, 10600 Plasencia, Cáceres, Spain
12Servicio de Hematología, Hospital Río Carrión, Avenida Donantes de Sangre, s/n, 34005 Palencia, Spain

Received 18 December 2013; Revised 7 February 2014; Accepted 24 February 2014; Published 30 March 2014

Academic Editor: Paola Dal Cin

Copyright © 2014 I. González-Gascón y Marín et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Dighiero and T. Hamblin, “Chronic lymphocytic leukaemia,” The Lancet, vol. 371, no. 9617, pp. 1017–1029, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Hernández, M. González, and J. M. Hernández, “Chronic lymphocytic leukemia,” Medicina Clínica, vol. 135, no. 4, pp. 172–178, 2010. View at Google Scholar
  3. K. R. Rai, A. Sawitsky, and E. P. Cronkite, “Clinical staging of chronic lymphocytic leukemia,” Blood, vol. 46, no. 2, pp. 219–234, 1975. View at Google Scholar · View at Scopus
  4. J. L. Binet, A. Auquier, G. Dighiero et al., “A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis,” Cancer, vol. 48, no. 1, pp. 198–206, 1981. View at Google Scholar
  5. M. Crespo, F. Bosch, N. Villamor et al., “ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia,” The New England Journal of Medicine, vol. 348, no. 18, pp. 1764–1775, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. E. Rodríguez-Vicente, M. G. Díaz, and J. M. Hernández-Rivas, “Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease,” Cancer Genetics, vol. 206, no. 3, pp. 49–62, 2013. View at Google Scholar
  7. N. Chiorazzi, “Implications of new prognostic markers in chronic lymphocytic leukemia,” Hematology, vol. 2012, pp. 76–87, 2012. View at Google Scholar
  8. R. N. Damle, T. Wasil, F. Fais et al., “Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia,” Blood, vol. 94, no. 6, pp. 1840–1847, 1999. View at Google Scholar · View at Scopus
  9. T. J. Hamblin, Z. Davis, A. Gardiner, D. G. Oscier, and F. K. Stevenson, “Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia,” Blood, vol. 94, no. 6, pp. 1848–1854, 1999. View at Google Scholar · View at Scopus
  10. J. A. Hernández, A. E. Rodríguez, M. González et al., “A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia,” Haematologica, vol. 94, no. 3, pp. 364–371, 2009. View at Google Scholar
  11. H. Döhner, S. Stilgenbauer, A. Benner et al., “Genomic aberrations and survival in chronic lymphocytic leukemia,” The New England Journal of Medicine, vol. 343, no. 26, pp. 1910–1916, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Ghia, K. Stamatopoulos, C. Belessi et al., “Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene,” Blood, vol. 105, no. 4, pp. 1678–1685, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Panovska-Stavridis, M. Ivanovski, N. Siljanovski, L. Cevreska, and D. G. Efremov, “Chronic lymphocytic leukemia patients with a V1-69 gene rearrangement do not have inferior survival with respect to patients that express other unmutated VH genes,” Leukemia Research, vol. 31, no. 2, pp. 245–248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Thorsélius, A. Kröber, F. Murray et al., “Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status,” Blood, vol. 107, no. 7, pp. 2889–2894, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. N. L. Harris, E. S. Jaffe, J. Diebold et al., “World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie house, Virginia, November 1997,” Journal of Clinical Oncology, vol. 17, no. 12, pp. 3835–3849, 1999. View at Google Scholar · View at Scopus
  16. B. D. Cheson, J. M. Bennett, M. Grever et al., “National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment,” Blood, vol. 87, no. 12, pp. 4990–4997, 1996. View at Google Scholar · View at Scopus
  17. P. Ghia, K. Stamatopoulos, C. Belessi et al., “ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia,” Leukemia, vol. 21, no. 1, pp. 1–3, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. J. M. van Dongen, A. W. Langerak, M. Brüggemann et al., “Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936,” Leukemia, vol. 17, no. 12, pp. 2257–2317, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. B. González, J. M. Hernández, J. L. García et al., “The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma,” Haematologica, vol. 89, no. 10, pp. 1213–1218, 2004. View at Google Scholar
  20. S. Quijano, A. López, A. Rasillo et al., “Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patients,” Blood, vol. 111, no. 10, pp. 5130–5141, 2008. View at Google Scholar
  21. M. Hojjat-Farsangi, M. Jeddi-Tehrani, S. M. Razavi et al., “Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia,” Cancer Science, vol. 100, no. 12, pp. 2346–2353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Chen, Y. Zhang, W. Zheng et al., “Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia,” Leukemia Research, vol. 32, no. 10, pp. 1491–1498, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Stanganelli, A. Travella, R. Bezares, and I. Slavutsky, “Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia,” Clinical Lymphoma Myeloma and Leukemia, vol. 13, no. 4, pp. 447.e2–457.e2, 2013. View at Google Scholar
  24. T. Karan-Djurasevic, V. Palibrk, T. Kostic et al., “Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia,” Clinical Lymphoma Myeloma and Leukemia, vol. 12, no. 4, pp. 252–260, 2012. View at Google Scholar
  25. I. Kryachok, I. Abramenko, N. Bilous, A. Chumak, Z. Martina, and I. Filonenko, “IGHV gene rearrangements as outcome predictors for CLL patients: experience of Ukrainian group,” Medical Oncology, vol. 29, no. 2, pp. 1093–1101, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. P. M. Donisi, N. Di Lorenzo, M. Riccardi et al., “Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a northeastern region of Italy,” Diagnostic Molecular Pathology, vol. 15, no. 4, pp. 206–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Bomben, M. Dal Bo, D. Capello et al., “Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study,” Blood, vol. 109, no. 7, pp. 2989–2998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Cahill, L. A. Sutton, M. Jansson et al., “IGHV3-21 gene frequency in a Swedish cohort of patients with newly diagnosed chronic lymphocytic leukemia,” Clinical Lymphoma Myeloma and Leukemia, vol. 12, no. 3, pp. 201–206, 2012. View at Google Scholar
  29. K. N. Potter, J. Orchard, E. Critchley, C. I. Mockridge, A. Jose, and F. K. Stevenson, “Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire,” Blood, vol. 101, no. 8, pp. 3082–3084, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. L.-A. Sutton, E. Kostareli, A. Hadzidimitriou et al., “Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen,” Blood, vol. 114, no. 20, pp. 4460–4468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. D. E. Gladstone, A. Blackford, E. Cho et al., “The importance of IGHV mutational status in del(11q) and del(17p) chronic lymphocytic leukemia,” Clinical Lymphoma, Myeloma and Leukemia, vol. 12, no. 2, pp. 132–137, 2012. View at Publisher · View at Google Scholar · View at Scopus